No daughter should ever have to die from cervical cancer.
Following the decision made on the proposed agenda “HPV vaccination campaign” by the executive board of the municipality on the 13th executive meeting of the fiscal year 2081/082 on the date 2081/10/13 (26th January 2025) The HPV Vaccination campaign has now been running in the municipality which aims to significantly reduce their risk of developing cervical cancer and other HPV-related diseases later in life.
About HPV and Importance of Vaccination
Human Papillomavirus (HPV) is a common virus that can lead to serious health issues, notably one being the cervical cancer, which is one of the leading causes of cancer-related deaths among women in Nepal and across the globe. Human Papillomavirus (HPV) is also linked to other cancers, such as those of the throat, anus, and genitals, as well as genital warts.
The good news is that cervical cancer is preventable, and the HPV vaccine is a powerful tool for the prevention. The vaccine is most effective when administered to girls aged 10 to 14 years, as it provides the strongest immune response before they are exposed to the virus. By vaccinating girls between 10-14 years of age group, we can significantly reduce their risk of developing cervical cancer and other HPV-related diseases later in life.
Immense positive results from the usage of the vaccine across the globe.
Developed countries have already implemented this vaccine, and its administration among girls aged 10–14 years has shown remarkable benefits. According to global health institutions like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), HPV vaccination in this age group has proven to be highly effective in preventing infections from HPV types 16 and 18, which are responsible for approximately 70% of cervical cancer cases worldwide. Reports by the International Studies regarding HPV clearly shows that the vaccination among age group 9–14 years age group of girls generate a higher stronger immune response compared to older age groups, making this the optimal window for vaccination.
Additionally, WHO and CDC emphasize that a one or two-dose schedule offers long-lasting protection, reducing the need for additional booster doses in the future. Countries with high HPV vaccination coverage have reported significant declines in HPV-related diseases, including cervical cancer and genital warts. For instance, in the United States, HPV vaccine-type infections have decreased by 86% among teenage girls since its introduction. This vaccine’s proven safety and cost-effectiveness make it an essential tool in global efforts to eliminate cervical cancer, particularly in low- and middle-income countries where the burden is highest. By prioritizing HPV vaccination for girls aged 10–14 years, nations can take a critical step toward safeguarding future generations from preventable HPV-related diseases.
Vaccination across Nepal and Suryodaya Municipality.
With the aim of reducing HPV infections among Nepal’s future generations and to ensure that citizens and working class of the future of the nation live healthy lives, the HPV vaccination campaign is being carried out across all local levels in Nepal. This initiative is crucial in protecting individuals from this potentially life-threatening virus and securing a healthier future for the nation.
However, some of our school girls are being deprived of this vaccination due to their parents’ decisions. There may be some misconceptions, but I assure you, this vaccine is safe and effective. Let us come together to protect our daughters from cervical cancer and fight against such life-threatening diseases.
This campaign is for students from grades 6 to 10, and for any girls who may have missed it at school, we are also offering it to girls aged 10 to 14.
Let us make this campaign a success and safeguard the future of our daughters.